![Kelly Gold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kelly Gold
Finansdirektör/CFO på
CAMP4 THERAPEUTICS CORPORATION
Förmögenhet: 256 777 $ per 2026-07-31
Profil
Kelly Gold is currently Director & Director-Individual Fundraising at Education First, Independent Director at X4 Pharmaceuticals, Inc. starting in 2026, and Chief Financial Officer at CAMP4 Therapeutics Corp.
since 2022.
Former roles include Associate Director-Strategic Corporate Finance at Biogen, Inc. from 2014 to 2017 and Partner at Deutsche Bank AG (New York Branch) from 2009 to 2013.
Education includes an undergraduate degree from Queen's University and an MBA from MIT Sloan School of Management.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-03 | 74 428 ( 0,14 % ) | 256 777 $ | 2026-07-31 |
Aktiva positioner av Kelly Gold
| Företag | Position | Start |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Finansdirektör/CFO | 2022-04-01 |
| X4 PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2026-06-01 |
Education First
 Education First Investment Trusts/Mutual FundsMiscellaneous Offers scholarship programs | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Kelly Gold
| Företag | Position | Slut |
|---|---|---|
| BIOGEN INC. | Företagsledare/Principal | 2017-01-01 |
Deutsche Bank AG (New York Branch)
 Deutsche Bank AG (New York Branch) Regional BanksFinance Provides financial and investment banking services | Företagsledare/Principal | 2013-01-01 |
Kelly Golds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
66
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Deutsche Bank AG (New York Branch)
Deutsche Bank AG (New York Branch) Regional BanksFinance Provides financial and investment banking services | Finance |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Education First
Education First Investment Trusts/Mutual FundsMiscellaneous Offers scholarship programs | Miscellaneous |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
